Wake Forest Institute for Regenerative Medicine is leading a
unique $24 million federally funded project to develop a "body on a
chip" that will be used to model the body's response to harmful
chemical and biological agents and develop potential
treatments.
The project involves using human cells to create tiny organ-like
structures that mimic the function of the heart, liver, lung and
blood vessels. Placed on a 2-inch chip, these structures will be
connected to a system of fluid channels and sensors to provide
on-line monitoring of individual organs and the overall organ
system.
The circulating blood substitute will keep the cells alive and
can be used to introduce chemical or biologic agents, as well as
potential therapies, into the system. Hollow channels will
automatically guide the toxins or therapies that are being
evaluated from one tissue to the next and sensors will measure
real-time temperature, oxygen levels, PH and other factors.
While the
idea of culturing 3-D human tissue on a chip is not new, this will
be one of the first efforts to combine several organs in the same
device to model the human response to chemical toxins or biologic
agents.
Brigham and Women’s Hospital, Boston – micro- and nanoscale bioengineering devices for controlling cellular behavior.
University of Michigan – microscale models of the body and biomolecular devices and technologies for high-throughput drug testing.
The U.S. Army Edgewood Chemical Biological Center – chemical warfare agent research, development, engineering, and testing.
Morgan State University – laboratory testing of cell cultures to identify the ideal blood surrogate.
The Johns Hopkins Bloomberg School of Public Health – toxicity testing and identification.
No comments:
Post a Comment